Kka Bi Son

Title: Kka Bi Son: Innovator in Cytokine Trimer Domain Technology.

Introduction

Kka Bi Son is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative fusion proteins. His work focuses on enhancing the binding capabilities of antibodies, which has important implications for pharmaceutical applications.

Latest Patents

Kka Bi Son holds a patent for a fusion protein comprising an antigen binding domain and a cytokine trimer domain. This invention relates to a cytokine trimer domain where a first monomer and a second monomer are linked by a linker, and a third monomer is coupled through a knob-into-hole mechanism. The novel fusion protein, known as receptor-antibody conjugated (cell) engager, or RACE, is created by replacing the constant region of an antibody with the cytokine trimer domain. RACE demonstrates superior binding ability to the target receptor compared to the parent antibody, as well as excellent simultaneous binding to both the antigen and the target receptor. This innovation can be effectively utilized as a bispecific pharmaceutical composition.

Career Highlights

Kka Bi Son is currently associated with Ctcells, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, particularly in the area of therapeutic proteins.

Collaborations

Kka Bi Son collaborates with talented individuals in his field, including Jeong Hyeon Bak and Dae Hee Lee. These collaborations enhance the innovative potential of his projects and contribute to the advancement of biotechnology.

Conclusion

Kka Bi Son's contributions to the field of biotechnology, particularly through his patented innovations, highlight his role as a leading inventor. His work on fusion proteins has the potential to significantly impact pharmaceutical development and therapeutic applications.